Vitaflo
PharmaceuticalsUnited States11-50 Employees
Vitaflo is a United States-based pharmaceutical manufacturer focused on specialized therapeutic nutrition for inherited metabolic disorders and disease-related malnutrition. In managing inherited metabolic disorders, the company has developed a new generation of protein substitutes for amino acid metabolism disorders, designed to be quick, convenient, and easier to use than older preparations, and taken as a concentrated low-volume drink. For disease-related malnutrition, Vitaflo offers a range of innovative products intended to add energy and protein to foods. These products address the needs of patients requiring dietary management of metabolic and nutritional conditions, seeking practical options that can simplify adherence. The organization operates as a small to mid-sized company within the pharmaceutical manufacturing industry. In May 2026, a leadership change was reported with the departure of the chief people officer.